Keyword: MedImmune

Dr. Jane Osbourn - AstraZeneca's MedImmune

Dr. Jane Osbourn decided to go into biopharma for two reasons: She had a passion for science, and she wanted to make a difference in patients’ lives. So, in September 1993, she joined what was then known as the Cambridge Antibody Technology Centre (CAT), and, talking to Fierce 23 years later, she said her love of science goes back even further.